Abstract
Background: Angiotensin Converting Enzyme (ACE) 2 is an important modulator of the Renin Angiotensin System (RAS) and the RAS plays a central role in renovascular hypertension. Very few studies investigated the role of components of the counterregulatory RAS axis (ACE2, Ang-(1-7) and Mas receptor) in renovascular hypertension and the results are controversial.
Objective: The aim of this study was to investigate the effects of Diminazene Aceturate (DIZE) administration on renal function and renal inflammation parameters in 2K1C hypertensive rats.
Methods: Male Wistar rats were divided into three experimental groups: sham-operated animals, 2K1C+saline and 2K1C+DIZE orally (1 mg/kg/day). At the end of the 30 days of treatment, renal function was analyzed and kidneys from all the groups were collected and processed separately for measurement of N-acetyl-beta-D-glucosaminidase (NAG) and Myeloperoxidase (MPO) activities, cytokines, chemokines and nitric oxide levels.
Results: Oral DIZE administration for 4 weeks in hypertensive rats attenuated renal dysfunction and reduced the levels of MPO and NAG, cytokines and chemokines (IL1β, IL-6, TNF-α and MCP-1) and increased urinary nitrate/nitrite levels in 2K1C hypertensive rats.
Conclusion: Our findings showed that ACE2 activation may effectively improve renal alterations and inflammation induced by renovascular hypertension.
Keywords: ACE2 activation, diminazene aceturate, angiotensin-(1-7), renoprotection, renovascular hypertension, renin angiotensin system.
Graphical Abstract
[1]
Santos, R.A. Ferreira, A.J.; Verano-Braga, T.; Bader M. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: New players of the renin-angiotensin system. J. Endocrinol., 2013, 216, 1-17. [http://dx.doi.org/10.1530/JOE-12-0341].
[2]
Pickering, T.G. Renovascular hypertension: etiology and pathophysiology. Semin. Nucl. Med., 1989, 19(2), 79-88. [http://dx.doi.org/10.1016/S0001-2998(89)80003-0]. [PMID: 2652313].
[3]
Hackenthal, E.; Paul, M.; Ganten, D.; Taugner, R. Morphology, physiology, and molecular biology of renin secretion. Physiol. Rev., 1990, 70(4), 1067-1116. [http://dx.doi.org/10.1152/physrev.1990.70.4.1067]. [PMID: 2217555].
[4]
Deschepper, C.F. Angiotensinogen: Hormonal regulation and relative importance in the generation of angiotensin II. Kidney Int., 1994, 46(6), 1561-1563. [http://dx.doi.org/10.1038/ki.1994.446]. [PMID: 7700006].
[5]
Atlas, S.A. The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition. J. Manag. Care Pharm., 2007, 13(8)(Suppl. B), 9-20. [http://dx.doi.org/10.18553/jmcp.2007.13.s8-b.9]. [PMID: 17970613].
[6]
Kaschina, E.; Unger, T. Angiotensin AT1/AT2 receptors: Regulation, signalling and function. Blood Press., 2003, 12(2), 70-88. [http://dx.doi.org/10.1080/08037050310001057]. [PMID: 12797627].
[7]
Crowley, S.D.; Gurley, S.B.; Herrera, M.J.; Ruiz, P.; Griffiths, R.; Kumar, A.P.; Kim, H.S.; Smithies, O.; Le, T.H.; Coffman, T.M. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl. Acad. Sci. USA, 2006, 103(47), 17985-17990. [http://dx.doi.org/10.1073/pnas.0605545103]. [PMID: 17090678].
[8]
Bivol, L.M.; Berge, R.K.; Iversen, B.M. Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008, 294(2), R438-R447. [http://dx.doi.org/10.1152/ajpregu.00590.2007]. [PMID: 18032469].
[9]
Agarwal, R.; Campbell, R.C.; Warnock, D.G. Oxidative stress in hypertension and chronic kidney disease: Role of angiotensin II. Semin. Nephrol., 2004, 24(2), 101-114. [http://dx.doi.org/10.1016/j.semnephrol.2003.11.008]. [PMID: 15017522].
[10]
Minuz, P.; Patrignani, P.; Gaino, S.; Degan, M.; Menapace, L.; Tommasoli, R.; Seta, F.; Capone, M.L.; Tacconelli, S.; Palatresi, S.; Bencini, C.; Del Vecchio, C.; Mansueto, G.; Arosio, E.; Santonastaso, C.L.; Lechi, A.; Morganti, A.; Patrono, C. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation, 2002, 106(22), 2800-2805. [http://dx.doi.org/10.1161/01.CIR.0000039528.49161.E9]. [PMID: 12451006].
[11]
Montezano, A.C.; Touyz, R.M. Reactive oxygen species, vascular Noxs, and hypertension: Focus on translational and clinical research. Antioxid. Redox Signal., 2014, 20(1), 164-182. [http://dx.doi.org/10.1089/ars.2013.5302]. [PMID: 23600794].
[12]
Navar, L.G.; Zou, L.; Von Thun, A.; Tarng Wang, C.; Imig, J.D.; Mitchell, K.D. Unraveling the mystery of Goldblatt hypertension. News Physiol. Sci., 1998, 13, 170-176. [PMID: 11390784].
[13]
Tipnis, S.R.; Hooper, N.M.; Hyde, R.; Karran, E.; Christie, G.; Turner, A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem., 2000, 275(43), 33238-33243. [http://dx.doi.org/10.1074/jbc.M002615200]. [PMID: 10924499].
[14]
Donoghue, M.; Hsieh, F.; Baronas, E.; Godbout, K.; Gosselin, M.; Stagliano, N.; Donovan, M.; Woolf, B.; Robison, K.; Jeyaseelan, R.; Breitbart, R.E.; Acton, S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res., 2000, 87(5), E1-E9. [http://dx.doi.org/10.1161/01.RES.87.5.e1]. [PMID: 10969042].
[15]
Santos, R.A.; Simoes e Silva, A.C.; Maric, C.; Silva, D.M.; Machado, R.P.; de Buhr, I.; Heringer-Walther, S.; Pinheiro, S.V.; Lopes, M.T.; Bader, M.; Mendes, E.P.; Lemos, V.S.; Campagnole-Santos, M.J.; Schultheiss, H.P.; Speth, R.; Walther, T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. USA, 2003, 100(14), 8258-8263. [http://dx.doi.org/10.1073/pnas.1432869100]. [PMID: 12829792].
[16]
Bürgelová, M.; Vanourková, Z.; Thumová, M.; Dvorák, P.; Opocenský, M.; Kramer, H.J.; Zelízko, M.; Malý, J.; Bader, M.; Cervenka, L. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. J. Hypertens., 2009, 27(10), 1988-2000. [http://dx.doi.org/10.1097/HJH.0b013e32832f0d06]. [PMID: 19593210].
[17]
Shah, A.; Oh, Y.B.; Lee, S.H.; Lim, J.M.; Kim, S.H. Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats. Am. J. Physiol. Heart Circ. Physiol., 2012, 302(11), H2372-H2380. [http://dx.doi.org/10.1152/ajpheart.00846.2011]. [PMID: 22467306].
[18]
Rakušan, D.; Bürgelová, M.; Vaněčková, I.; Vaňourková, Z.; Husková, Z.; Skaroupková, P.; Mrázová, I.; Opočenský, M.; Kramer, H.J.; Netuka, I.; Malý, J.; Alenina, N.; Bader, M.; Santos, R.A.; Cervenka, L. Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: Roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II. Kidney Blood Press. Res., 2010, 33(6), 476-488. [http://dx.doi.org/10.1159/000320689]. [PMID: 21071955].
[19]
Qi, Y.; Zhang, J.; Cole-Jeffrey, C.T.; Shenoy, V.; Espejo, A.; Hanna, M.; Song, C.; Pepine, C.J.; Katovich, M.J.; Raizada, M.K. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension, 2013, 62(4), 746-752. [http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.01337]. [PMID: 23959549].
[20]
De Maria, M.L.; Araújo, L.D.; Fraga-Silva, R.A.; Pereira, L.A.; Ribeiro, H.J.; Menezes, G.B.; Shenoy, V.; Raizada, M.K.; Ferreira, A.J. Anti-hypertensive effects of diminazene aceturate: An angiotensin-converting enzyme 2 activator in rats. Protein Pept. Lett., 2016, 23(1), 9-16. [http://dx.doi.org/10.2174/0929866522666151013130550]. [PMID: 26458404].
[21]
Velkoska, E.; Patel, S.K.; Griggs, K.; Pickering, R.J.; Tikellis, C.; Burrell, L.M. Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy. PLoS One, 2015, 10(3)e0118758 [http://dx.doi.org/10.1371/journal.pone.0118758]. [PMID: 25786223].
[22]
Mecca, A.P.; Regenhardt, R.W.; O’Connor, T.E.; Joseph, J.P.; Raizada, M.K.; Katovich, M.J.; Sumners, C. Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol., 2011, 96(10), 1084-1096. [http://dx.doi.org/10.1113/expphysiol.2011.058578]. [PMID: 21685445].
[23]
Qiu, Y.; Shil, P.K.; Zhu, P.; Yang, H.; Verma, A.; Lei, B.; Li, Q. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice. Invest. Ophthalmol. Vis. Sci., 2014, 55(6), 3809-3818. [http://dx.doi.org/10.1167/iovs.14-13883]. [PMID: 24854854].
[24]
Goldblatt, H.; Lynch, J.; Hanzal, R.F.; Summerville, W.W. Studies on experimental hypertension: The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med., 1934, 59(3), 347-379. [http://dx.doi.org/10.1084/jem.59.3.347]. [PMID: 19870251].
[25]
Cervenka, L.; Wang, C.T.; Mitchell, K.D.; Navar, L.G. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension, 1999, 33(1), 102-107. [http://dx.doi.org/10.1161/01.HYP.33.1.102]. [PMID: 9931089].
[26]
Allred, A.J.; Diz, D.I.; Ferrario, C.M.; Chappell, M.C. Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues. Am. J. Physiol. Renal Physiol., 2000, 279(5), F841-F850. [http://dx.doi.org/10.1152/ajprenal.2000.279.5.F841]. [PMID: 11053044].
[27]
Navar, L.G.; Nishiyama, A. Why are angiotensin concentrations so high in the kidney? Curr. Opin. Nephrol. Hypertens., 2004, 13(1), 107-115. [http://dx.doi.org/10.1097/00041552-200401000-00015]. [PMID: 15090867].
[28]
Jaimes, E.A.; Tian, R.X.; Pearse, D.; Raij, L. Up-regulation of glomerular COX-2 by angiotensin II: Role of reactive oxygen species. Kidney Int., 2005, 68(5), 2143-2153. [http://dx.doi.org/10.1111/j.1523-1755.2005.00670.x]. [PMID: 16221213].
[29]
Ren, Y.; Garvin, J.L.; Carretero, O.A. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension, 2002, 39(3), 799-802. [http://dx.doi.org/10.1161/hy0302.104673]. [PMID: 11897767].
[30]
Sampaio, W.O.; Nascimento, A.A.; Santos, R.A. Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am. J. Physiol. Heart Circ. Physiol., 2003, 284(6), H1985-H1994. [http://dx.doi.org/10.1152/ajpheart.01145.2002]. [PMID: 12573992].
[31]
Stegbauer, J.; Oberhauser, V.; Vonend, O.; Rump, L.C. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats. Cardiovasc. Res., 2004, 61(2), 352-359. [http://dx.doi.org/10.1016/j.cardiores.2003.11.017]. [PMID: 14736552].
[32]
Pinheiro, S.V.B.; Ferreira, A.J.; Kitten, G.T.; da Silveira, K.D.; da Silva, D.A.; Santos, S.H.S.; Gava, E.; Castro, C.H.; Magalhães, J.A.; da Mota, R.K.; Botelho-Santos, G.A.; Bader, M.; Alenina, N.; Santos, R.A.S.; Simoes, E.; Silva, A.C. Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney Int., 2009, 75(11), 1184-1193. [http://dx.doi.org/10.1038/ki.2009.61]. [PMID: 19262461].
[33]
Silveira, K.D.; Barroso, L.C.; Vieira, A.T.; Cisalpino, D.; Lima, C.X.; Bader, M.; Arantes, R.M.; Dos Santos, R.A.; Simões-E-Silva, A.C.; Teixeira, M.M. Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy. PLoS One, 2013, 8(6)e66082 [http://dx.doi.org/10.1371/journal.pone.0066082]. [PMID: 23762470].
[34]
Barroso, L.C.; Silveira, K.D.; Lima, C.X.; Borges, V.; Bader, M.; Rachid, M.; Santos, R.A.; Souza, D.G.; Simões, E. Silva, A.C.; Teixeira, M.M. Renoprotective effects of AVE0991, a nonpeptide mass receptor agonist, in experimental acute renal injury. Int. J. Hypertens., 2012, 2012808726 [http://dx.doi.org/10.1155/2012/808726]. [PMID: 22319645].
[35]
Li, Y.; Wu, J.; He, Q.; Shou, Z.; Zhang, P.; Pen, W.; Zhu, Y.; Chen, J. Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice. Hypertens. Res., 2009, 32(5), 369-374. [http://dx.doi.org/10.1038/hr.2009.25]. [PMID: 19325560].
[36]
Dilauro, M.; Zimpelmann, J.; Robertson, S.J.; Genest, D.; Burns, K.D. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am. J. Physiol. Renal Physiol., 2010, 298(6), F1523-F1532. [http://dx.doi.org/10.1152/ajprenal.00426.2009]. [PMID: 20357030].
[37]
Oudit, G.Y.; Herzenberg, A.M.; Kassiri, Z.; Wong, D.; Reich, H.; Khokha, R.; Crackower, M.A.; Backx, P.H.; Penninger, J.M.; Scholey, J.W. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am. J. Pathol., 2006, 168(6), 1808-1820. [http://dx.doi.org/10.2353/ajpath.2006.051091]. [PMID: 16723697].
[38]
Soler, M.J.; Wysocki, J.; Ye, M.; Lloveras, J.; Kanwar, Y.; Batlle, D. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int., 2007, 72(5), 614-623. [http://dx.doi.org/10.1038/sj.ki.5002373]. [PMID: 17579661].
[39]
Wong, D.W.; Oudit, G.Y.; Reich, H.; Kassiri, Z.; Zhou, J.; Liu, Q.C.; Backx, P.H.; Penninger, J.M.; Herzenberg, A.M.; Scholey, J.W. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol., 2007, 171(2), 438-451. [http://dx.doi.org/10.2353/ajpath.2007.060977]. [PMID: 17600118].
[40]
Ye, M.; Wysocki, J.; William, J.; Soler, M.J.; Cokic, I.; Batlle, D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol., 2006, 17(11), 3067-3075. [http://dx.doi.org/10.1681/ASN.2006050423]. [PMID: 17021266].
[41]
da Silveira, K.D.; Pompermayer Bosco, K.S.; Diniz, L.R.; Carmona, A.K.; Cassali, G.D.; Bruna-Romero, O.; de Sousa, L.P.; Teixeira, M.M.; Santos, R.A.; Simões e Silva, A.C.; Ribeiro Vieira, M.A. ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clin. Sci. (Lond.), 2010, 119(9), 385-394. [http://dx.doi.org/10.1042/CS20090554]. [PMID: 20528771].
[42]
Lara, L.S.; De Carvalho, T.; Leão-Ferreira, L.R.; Lopes, A.G.; Caruso-Neves, C. Modulation of the (Na(+)+K+)ATPase activity by Angiotensin-(1-7) in MDCK cells. Regul. Pept., 2005, 129(1-3), 221-226. [http://dx.doi.org/10.1016/j.regpep.2005.02.014]. [PMID: 15927719].
[43]
DelliPizzi, A.M.; Hilchey, S.D.; Bell-Quilley, C.P. Natriuretic action of angiotensin (1-7). Br. J. Pharmacol., 1994, 111(1), 1-3. [http://dx.doi.org/10.1111/j.1476-5381.1994.tb14014.x]. [PMID: 8012686].
[44]
Vallon, V.; Richter, K.; Heyne, N.; Osswald, H. Effect of intratubular application of angiotensin 1-7 on nephron function. Kidney Blood Press. Res., 1997, 20(4), 233-239. [http://dx.doi.org/10.1159/000174151]. [PMID: 9398028].
[45]
Bürgelová, M.; Kramer, H.J.; Teplan, V.; Velicková, G.; Vítko, S.; Heller, J.; Malý, J.; Cervenka, L. Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat. Kidney Blood Press. Res., 2002, 25(4), 202-210. [http://dx.doi.org/10.1159/000066340]. [PMID: 12424421].
[46]
Santos, R.A.; Simões e Silva, A.C.; Magaldi, A.J.; Khosla, M.C.; Cesar, K.R.; Passaglio, K.T.; Baracho, N.C. Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension, 1996, 27(4), 875-884. [http://dx.doi.org/10.1161/01.HYP.27.4.875]. [PMID: 8613263].
[47]
Simões e Silva, A.C.; Bello, A.P.; Baracho, N.C.; Khosla, M.C.; Santos, R.A. Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1-7) antagonist in normotensive and hypertensive rats. Regul. Pept., 1998, 74(2-3), 177-184. [http://dx.doi.org/10.1016/S0167-0115(98)00038-X]. [PMID: 9712179].
[48]
Magaldi, A.J.; Cesar, K.R.; de Araújo, M.; Simões e Silva, A.C.; Santos, R.A. Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: Evidence for involvement of vasopressin V2 receptors. Pflugers Arch., 2003, 447(2), 223-230. [http://dx.doi.org/10.1007/s00424-003-1173-1]. [PMID: 14534790].
[49]
Pinheiro, S.V.; Simões e Silva, A.C.; Sampaio, W.O.; de Paula, R.D.; Mendes, E.P.; Bontempo, E.D.; Pesquero, J.B.; Walther, T.; Alenina, N.; Bader, M.; Bleich, M.; Santos, R.A. Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension, 2004, 44(4), 490-496. [http://dx.doi.org/10.1161/01.HYP.0000141438.64887.42]. [PMID: 15326087].
[50]
Baracho, N.C.; Simões-e-Silva, A.C.; Khosla, M.C.; Santos, R.A. Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats. Braz. J. Med. Biol. Res., 1998, 31(9), 1221-1227. [http://dx.doi.org/10.1590/S0100-879X1998000900016]. [PMID: 9876290].
[51]
Vianna, H.R.; Soares, C.M.; Tavares, M.S.; Teixeira, M.M.; Silva, A.C. Inflammation in chronic kidney disease: the role of cytokines. J. Bras. Nefrol., 2011, 33(3), 351-364. [http://dx.doi.org/10.1590/S0101-28002011000300012]. [PMID: 22042353].
[52]
Matavelli, L.C.; Huang, J.; Siragy, H.M. Angiotensin AT2 receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension, 2011, 57(2), 308-313. [http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.164202]. [PMID: 21189405].
[53]
Cheng, J.; Zhou, W.; Warner, G.M.; Knudsen, B.E.; Garovic, V.D.; Gray, C.E.; Lerman, L.O.; Platt, J.L.; Romero, J.C.; Textor, S.C.; Nath, K.A.; Grande, J.P. Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am. J. Physiol. Renal Physiol., 2009, 297(4), F1055-F1068. [http://dx.doi.org/10.1152/ajprenal.90439.2008]. [PMID: 19625373].
[54]
Zheng, C.; Lei, C.; Chen, Z.; Zheng, S.; Yang, H.; Qiu, Y.; Lei, B. Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis. Mol. Vis., 2015, 21, 403-411. [PMID: 25883526].
[55]
Tao, L.; Qiu, Y.; Fu, X.; Lin, R.; Lei, C.; Wang, J.; Lei, B. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium. J. Neuroinflammation, 2016, 13, 35. [http://dx.doi.org/10.1186/s12974-016-0489-7]. [PMID: 26862037].
[56]
Rodrigues Prestes, T.R.; Rocha, N.P.; Miranda, A.S.; Teixeira, A.L. Simoes-E-Silva, A.C. Simoes-E-Silva, A.C. The anti-inflammatory potential of ACE2/Angiotensin-(1-7)/Mas receptor axis: Evidence from basic and clinical research. Curr. Drug Targets, 2017, 18(11), 1301-1313. [http://dx.doi.org/10.2174/1389450117666160727142401]. [PMID: 27469342].
Call for Papers in Thematic Issues
01 February, 2025
Therapeutic Proteins and Peptides of Plant Origin
Plants are still the major repository of biologically active substances. In the last two decades, however, natural peptides and proteins of plant origin have gained increasing attention due to their pharmacological activities over a variety of human illnesses, including those mediated by infections and parasitosis and those involving different cellular ...read more
Related Books
The Future of Agriculture: IoT, AI and Blockchain Technology for Sustainable Farming
Handbook of Integrated Weed Management for Major Field Crops
Practical Biochemistry
Anticancer Drugs Sourced from Marine Life
Opportunities for Biotechnology Research and Entrepreneurship
Diseases of Ornamental, Aromatic and Medicinal Plants
Diabetes and Breast Cancer: An Analysis of Signaling Pathways
Fundamentals of Cellular and Molecular Biology
Industrial Applications of Soil Microbes
Genome Editing in Bacteria (Part 2)
Article Metrics
37
11
2
2
